C9orf72 in myeloid cells suppresses STING-induced inflammation

Madelyn E. McCauley, Jacqueline G. O’Rourke, Alberto Yáñez, +14

Nature

InflammationCytokineImmune Cell DevelopmentImmunologyChronic Inflammation +3

Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy

Anna Galstyan, Janet L. Markman, Ekaterina S. Shatalova, +18

Nature Communications

Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle

Benno Lickefett, Lulu Chu, Valentin Ortiz-Maldonado, +17

Frontiers in Immunology

MRI Virtual Biopsy and Treatment of Brain Metastatic Tumors with Targeted Nanobioconjugates: Nanoclinic in the Brain

Rameshwar Patil, Alexander V. Ljubimov, Pallavi R. Gangalum, +14

ACS Nano

Sex-Specific Effects of the Nlrp3 Inflammasome on Atherogenesis in LDL Receptor-Deficient Mice

Shuang Chen, Janet L. Markman, Kenichi Shimada, +5

JACC Basic to Translational Science

Loss of testosterone impairs anti-tumor neutrophil function

Janet L. Markman, Rebecca A. Porritt, Daiko Wakita, +7

Nature Communications

ImmunologyImmune RegulationPathologyImmunoeditingImmune System +15

Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model

Gantsetseg Tumurkhuu, Shuang Chen, Erica N. Montano, +14

Frontiers in Immunology

Interleukin-1 Beta–Mediated Sex Differences in Kawasaki Disease Vasculitis Development and Response to Treatment

Rebecca A. Porritt, Janet L. Markman, Daisuke Maruyama, +7

Arteriosclerosis Thrombosis and Vascular Biology

Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer

Satoshi Inoue, Rameshwar Patil, José Portilla‐Arias, +10

PLoS ONE

Novel NanobioconjugateEgfr ExpressionBreast OncologyNanotherapeuticsEngineering +21

Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment

Julia Y. Ljubimova, José Portilla‐Arias, Rameshwar Patil, +10

Journal of drug targeting

Breast OncologyNanotherapeuticsEngineeringImmunotherapeuticsBiomedical Engineering +19